Get In Touch
Xeraya Capital Sdn Bhd
26.03–26.08, G Tower
#199 Jalan Tun Razak, KL
xeraya@xeraya.com
+603 2381 8700
Submit a Proposal
proposal@xeraya.com
Back

News & Events

Latest news and events related to our activities and our portfolio partners.
  • Xeraya Admin
  • Posted by Xeraya Admin
October 4, 2022
5 min read

Endpoint Health Unveils Precision Immunology Program to Address Tissue Factor-Mediated Inflammation in Autoimmune Diseases

  • Xeraya Admin
  • Posted by Xeraya Admin
September 19, 2022
3 min read

P2 Science Wins the Prestigious BeautyMatter NEXT Award for Best Breakthrough Supplier

  • Xeraya Admin
  • Posted by Xeraya Admin
September 12, 2022
1 min read

InterVenn Biosciences at the Launch of DBN 2.0

  • Xeraya Admin
  • Posted by Xeraya Admin
August 24, 2022
1 min read

Malaysia SDG and ESG Impact Awards

  • Xeraya Admin
  • Posted by Xeraya Admin
August 3, 2022
3 min read

InterVenn Biosciences to make Malaysia its regional hub

  • Xeraya Admin
  • Posted by Xeraya Admin
August 2, 2022
4 min read

InterVenn Biosciences Announces Start of Enrollment in Colonoscopy Study

  • Xeraya Admin
  • Posted by Xeraya Admin
June 22, 2022
3 min read

Congenica appoints Robert Denison as CEO

  • Xeraya Admin
  • Posted by Xeraya Admin
June 1, 2022
4 min read

InterVenn Biosciences Joins the WIN and FNIH Biomarker Consortiums to Introduce a Glycoproteomic Option for Liquid Biopsies

  • Xeraya Admin
  • Posted by Xeraya Admin
May 12, 2022
2 min read

Congenica wins Technology Company of the Year

  • Xeraya Admin
  • Posted by Xeraya Admin
May 3, 2022
3 min read

Imago BioSciences Announces Completion of Enrollment in Phase 2 Clinical Study of Bomedemstat in Essential Thrombocythemia

  • Xeraya Admin
  • Posted by Xeraya Admin
May 3, 2022
3 min read

Living Proof and P2 Science Announce New Partnership

  • Xeraya Admin
  • Posted by Xeraya Admin
May 3, 2022
3 min read

Congenica Appoints Dr. Tom Barber as Chief Scientific Officer

  • Xeraya Admin
  • Posted by Xeraya Admin
April 27, 2022
4 min read

Acutus Medical sells left-heart access portfolio to Medtronic in $50M deal

  • Xeraya Admin
  • Posted by Xeraya Admin
March 15, 2022
4 min read

AI Biotech Lands In Victoria To Advance Early Cancer Detection

  • Xeraya Admin
  • Posted by Xeraya Admin
February 4, 2022
2 min read

Brief: Greenlight Biosciences completes $1.2bn merger to list on Nasdaq, closes up 5%

  • Xeraya Admin
  • Posted by Xeraya Admin
January 13, 2022
5 min read

Allecra Therapeutics and ADVANZ PHARMA Sign Exclusive License and Supply Agreement for Allecra's Antibiotic Cefepime/ enmetazobactam in Europe

  • Xeraya Admin
  • Posted by Xeraya Admin
December 15, 2021
1 min read

MVCA Awards 2020/2021

  • Xeraya Admin
  • Posted by Xeraya Admin
December 13, 2021
6 min read

Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn's Proprietary Gene Traffic Control Platform

  • Xeraya Admin
  • Posted by Xeraya Admin
November 30, 2021
5 min read

GreenLight Biosciences (ENVI) partners with IAVI to accelerate COVID-19 vaccine trial in Africa

  • Xeraya Admin
  • Posted by Xeraya Admin
November 23, 2021
3 min read

Serum Life Sciences invests in RNA biotech GreenLight by joining expanded financing for Environmental Impact Acquisition Corp.

  • Xeraya Admin
  • Posted by Xeraya Admin
September 21, 2021
4 min read

Congenica is Joint Winner of MIT Solve The Horizon Prize

  • Xeraya Admin
  • Posted by Xeraya Admin
August 10, 2021
4 min read

mRNA Disruptor Goes Public in $1.5 Billion SPAC Deal

  • Xeraya Admin
  • Posted by Xeraya Admin
August 2, 2021
3 min read

InterVenn Biosciences Raises $201 Million for AI-driven Glycoproteomic Platform, Liquid-Biopsy development

  • Xeraya Admin
  • Posted by Xeraya Admin
July 22, 2021
5 min read

Khazanah-backed Rapid Micro Biosystems listed on Nasdaq at US$20